137 related articles for article (PubMed ID: 1226786)
21. The use of the urinary excretion of delta-aminolevulinic acid as a criterion for lead absorption in industrial medicine and insurance medicine.
Lahaye D; Roosels D; Bossiroy JM; van Assche F
Int Arch Occup Environ Health; 1977 Aug; 39(3):191-8. PubMed ID: 924689
[No Abstract] [Full Text] [Related]
22. Response of free erythrocyte porphyrin and urinary delta-aminolevulinic acid in men and women moderately exposed to lead.
Roels HA; Lauwerys RR; Buchet JP; Vrelust MT
Int Arch Arbeitsmed; 1975; 34(2):97-108. PubMed ID: 1176176
[No Abstract] [Full Text] [Related]
23. Blood lead and maximal urinary excretion of delta-aminolevulinic acid.
Létourneau GG; Plante R; Weber JP
Am Ind Hyg Assoc J; 1988 Jul; 49(7):342-5. PubMed ID: 3407593
[TBL] [Abstract][Full Text] [Related]
24. [Determination of urinary delta-aminolevulinic acid using a descrete automatized analyzer].
Cavalleri A; Bianco L; Biscaldi GP
Med Lav; 1976; 67(2):145-51. PubMed ID: 1021707
[No Abstract] [Full Text] [Related]
25. [Aminolcevulinic acid excretion in women before and after delivery and in their newborn infants (authors transl)].
Maruna RF; Maruna H; Altmann P; Georgiades E; Michalica W
Wien Klin Wochenschr; 1975 Oct; 87(20):692-5. PubMed ID: 1220271
[TBL] [Abstract][Full Text] [Related]
26. [Correlation of concentrations of gamma aminolevulinic acid and creatinine in the urine (screening test for lead exposure by urinary spot samples)].
Kikuchi M; Nishima T
Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):108. PubMed ID: 1169457
[No Abstract] [Full Text] [Related]
27. [The value of determining delta-aminolevulinic acid in urine (method II, East German occupational monitoring) as a screening procedure for the assessment of internal residues in occupational exposure to lead].
Pannier R; Behning I; Praefke K; Hübner G
Z Gesamte Hyg; 1989 Jan; 35(1):22-3. PubMed ID: 2922940
[TBL] [Abstract][Full Text] [Related]
28. Statistical analysis of urinary delta-aminolevulinic acid (ALAU) excretion in the white-footed mouse associated with lead smelting.
Lower WR; Tsutakawa RK
J Environ Pathol Toxicol; 1978; 1(5):551-60. PubMed ID: 722203
[TBL] [Abstract][Full Text] [Related]
29. [Detection of lead poisoning in variously exposed day-care center infants by determining the delta-aminolevulinic acid (delta-ALA) concentration in the urine].
Manuwald O; Horn H; Gebser M
Z Gesamte Hyg; 1980; 26(5):349-51. PubMed ID: 7467538
[No Abstract] [Full Text] [Related]
30. [Use of urinary indicators of exposure to lead for epidemiological studies in preventive medicine].
Franchini I
Med Lav; 1978; 69(1):94-5. PubMed ID: 651777
[No Abstract] [Full Text] [Related]
31. [Determination of the urinary delta aminolevulinic acid. Levels in a Spanish population].
Tutor Valcarce JC; Trigo Vázquez E; García Devesa J; del rio Anido R
Rev Clin Esp; 1976 Aug; 142(3):205-9. PubMed ID: 968109
[No Abstract] [Full Text] [Related]
32. [A global ecological evaluation of the biological exposure test].
Petz J; Hrebacka J; Bufka L
Cas Lek Cesk; 1984 May; 123(18):542-6. PubMed ID: 6467306
[No Abstract] [Full Text] [Related]
33. [Delta-aminolevulinic acid, its importance for the detection of saturnism].
Lob M; Voirol MW
Schweiz Med Wochenschr; 1970 Dec; 100(49):2120-1. PubMed ID: 5495328
[No Abstract] [Full Text] [Related]
34. [Biochemical study of various occupational groups exposed to lead].
Kutter D; Machoud M
Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):35-41. PubMed ID: 699239
[No Abstract] [Full Text] [Related]
35. [Chronobiological study of the urinary excretion of delta-aminolevulinic acid in man].
Botta A; Bruguerolle B; Bartolin R; Bouvenot G
Rev Med Interne; 1986 Sep; 7(4):421-4. PubMed ID: 3797874
[No Abstract] [Full Text] [Related]
36. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
Massmann W
Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
[No Abstract] [Full Text] [Related]
37. [Comparative study between urinary excretion of delta-aminolevulinic acid and coproporphyrins in subjects exposed to lead].
Vivoli G; Rinaldi Ferrari L; Caselgrandi E
Nuovi Ann Ig Microbiol; 1973; 24(3):139-48. PubMed ID: 4786801
[No Abstract] [Full Text] [Related]
38. The effects of water restriction and water loading on urinary excretion of lead, delta-aminolevulinic acid and coproporphyrin.
Araki S
Br J Ind Med; 1978 Nov; 35(4):312-7. PubMed ID: 737138
[TBL] [Abstract][Full Text] [Related]
39. [Comparative examination of urinary delta-aminolevulinic acid].
Bauer S; Orusev T; Dogramadziev Z
God Zb Med Fak Skopje; 1977; 23():295-301. PubMed ID: 614990
[No Abstract] [Full Text] [Related]
40. Experimental lead intoxication in dogs: a comparison of blood lead and urinary delta-aminolevulinic acid following intoxication and chelation therapy.
Green RA; Selby LA; Zumwalt RW
Can J Comp Med; 1978 Apr; 42(2):205-13. PubMed ID: 667707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
